These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 104621)

  • 1. Post-transfusion alloimmunization in patients with sickle cell disease.
    Orlina AR; Unger PJ; Koshy M
    Am J Hematol; 1978; 5(2):101-6. PubMed ID: 104621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
    Jariwala K; Mishra K; Ghosh K
    Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion and alloimmunization in sickle cell anemia patients].
    Norol F; Nadjahi J; Bachir D; Desaint C; Guillou Bataille M; Beaujean F; Bierling P; Bonin P; Galacteros F; Duedari N
    Transfus Clin Biol; 1994; 1(1):27-34. PubMed ID: 8186850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients].
    Diarra AB; Guindo A; Kouriba B; Dorie A; Diabaté DT; Diawara SI; Fané B; Touré BA; Traoré A; Gulbis B; Diallo DA
    Transfus Clin Biol; 2013 Dec; 20(5-6):476-81. PubMed ID: 23916574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell alloimmunization in sickle cell disease.
    Davies SC; McWilliam AC; Hewitt PE; Devenish A; Brozovic M
    Br J Haematol; 1986 Jun; 63(2):241-5. PubMed ID: 3087406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood group alloantibodies: an assessment of some laboratory practices.
    Giblett ER
    Transfusion; 1977; 17(4):299-308. PubMed ID: 406699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens?
    Schonewille H; Brand A
    Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for alloimmunization in patients with sickle cell anemia.
    Pinto PC; Braga JA; Santos AM
    Rev Assoc Med Bras (1992); 2011; 57(6):668-73. PubMed ID: 22249547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients.
    Castilho L; Rios M; Bianco C; Pellegrino J; Alberto FL; Saad ST; Costa FF
    Transfusion; 2002 Feb; 42(2):232-8. PubMed ID: 11896340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
    Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
    Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease.
    Rosse WF; Gallagher D; Kinney TR; Castro O; Dosik H; Moohr J; Wang W; Levy PS
    Blood; 1990 Oct; 76(7):1431-7. PubMed ID: 2207318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-anti-D antibodies in red-cell alloimmunization.
    Moise KJ
    Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):75-81. PubMed ID: 10986438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloimmunization in two multitransfused patient populations.
    Coles SM; Klein HG; Holland PV
    Transfusion; 1981; 21(4):462-6. PubMed ID: 7268873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed hemolytic transfusion reaction caused by anti-LebH antibody.
    Weir AB; Woods LL; Chesney C; Neitzer G
    Vox Sang; 1987; 53(2):105-7. PubMed ID: 3120409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for alloimmunization by patients with sickle cell disease.
    Murao M; Viana MB
    Braz J Med Biol Res; 2005 May; 38(5):675-82. PubMed ID: 15917948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.